To accelerate the transition of therapies into clinical studies for patients, Accelerate Brain Cancer Cure has initiated a strategic collaboration, the ABC2 Clinical Network. It is composed of four leading neuro-oncology centers and clinical investigators who work together to:
The ABC2 Clinical Network serves as a resource to patients and the scientific and medical communities.
Members include the Preston Robert Tisch Brain Tumor Center at Duke University, the M.D. Anderson Cancer Center, the University of California-Los Angeles, and the University of California-San Francisco.
It is the vehicle through which ABC2 translates successes in the lab into meaningful treatment options for brain cancer patients and their families.
- Provide guidance and counsel to the sponsors of drug therapies, particularly in the early stages of designing clinical trials;
- Assist ABC2 in evaluating the potential or readiness of promising drug therapies for clinical trials; and
- Conduct clinical trials of these therapies.